<DOC>
	<DOCNO>NCT02783950</DOCNO>
	<brief_summary>To determine impact Decipher test result adjuvant treatment decision high-risk post-RP patient undetectable post-op prostate specific antigen ( PSA ) compare clinical factor alone .</brief_summary>
	<brief_title>Genomics Michigan Impacting Observation Radiation</brief_title>
	<detailed_description>This prospective , randomized trial compare receipt adjuvant therapy high-risk radical prostatectomy ( RP ) patient undergo Decipher test . 350 subject within statewide Michigan Urological Surgery Improvement Collaborative ( MUSIC ) randomize either Genomic Classifier ( Decipher ) Usual-Care-Based ( UC ) strategy period three month . If enrol Genomic Classifier period , subject treat physician provide Decipher result CAPRA-S score . In UC period , CAPRA-S score Decipher result provide .</detailed_description>
	<criteria>Prostate cancer patient undergone radical prostatectomy PSA &lt; 0.1 ng/ml enrollment At least one following : pT3 ( seminal vesicle invasion extraprostatic extension ) , Positive surgical margin Radical prostatectomy within one year enrollment Individuals follow eligible participate : Have regional distant metastatic disease Received radiation hormone therapy ( neoadjuvant , adjuvant , salvage ) Node positive</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Genomics</keyword>
	<keyword>Adjuvant Treatment</keyword>
</DOC>